MedPath

LISINOPRIL

Lisinopril Tablets USP2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg

Approved
Approval ID

4ebf9ad0-f03c-401f-a66c-7a6d93bcd290

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 8, 2010

Manufacturers
FDA

Blenheim Pharmacal, Inc.

DUNS: 171434587

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LISINOPRIL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10544-238
Application NumberANDA077321
Product Classification
M
Marketing Category
C73584
G
Generic Name
LISINOPRIL
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 8, 2010
FDA Product Classification

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LISINOPRILActive
Quantity: 10 mg in 1 1
Code: E7199S1YWR
Classification: ACTIB
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LISINOPRIL - FDA Drug Approval Details